J Gen Virol Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mulders, M. N.
Right arrow Articles by Koopmans, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mulders, M. N.
Right arrow Articles by Koopmans, M. P.
Agricola
Right arrow Articles by Mulders, M. N.
Right arrow Articles by Koopmans, M. P.

Journal of General Virology, Vol 80, 907-916, Copyright © 1999 by Society for General Microbiology


ARTICLES

A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1

MN Mulders, JH Reimerink, M Stenvik, I Alaeddinoglu, HG van der Avoort, T Hovi and MP Koopmans
Enterovirus Laboratory, Department of Virology, National Public Health Institute (KTL), Helsinki, Finland. Mick.Mulders@ktl.fi

Poliovirus strains derived from the oral poliovirus vaccine (Sabin) can be differentiated from wild-type poliovirus by tests based on either immunological or genetic properties of the strains. The characterization of a recently identified poliovirus type 1 isolate with exceptional properties is described. Initial phenotypic analysis of the virus by use of polyclonal absorbed antisera suggested a wild- type character. However, the different genomic analyses all confirmed the Sabin-derived character of the virus. All 17 plaques isolated from the strain shared these properties, thus excluding the possibility of a mixture of a wild-type and a Sabin-derived strain. To elucidate the properties of this virus further, the nucleotide sequences of the P1 region and most of the 5' non-coding region were established. Although the nucleotide identity with Sabin 1 was more than 99.4%, mutations were observed in regions encoding three major antigenic sites; the deduced amino acid substitutions confirmed the aberrant results of micro-neutralization assays with site-specific monoclonal antibodies. The most striking feature was the existence of a hexanucleotide deletion in the VP1 gene, which gave rise to a two amino acid deletion in the BC loop. In spite of these antigenic changes, the strain was readily serotyped as poliovirus type 1 under standard conditions. Likewise, replication of the virus under cell culture conditions was not affected by these mutations or by the deletion. Standard polio vaccination protects against this aberrant virus, and its epidemiological significance remains open.


This article has been cited by other articles:


Home page
J. Virol.Home page
J. K. Odoom, Z. Yunus, G. Dunn, P. D. Minor, and J. Martin
Changes in Population Dynamics during Long-Term Evolution of Sabin Type 1 Poliovirus in an Immunodeficient Patient
J. Virol., September 15, 2008; 82(18): 9179 - 9190.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Aragones, A. Bosch, and R. M. Pinto
Hepatitis A Virus Mutant Spectra under the Selective Pressure of Monoclonal Antibodies: Codon Usage Constraints Limit Capsid Variability
J. Virol., February 15, 2008; 82(4): 1688 - 1700.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
E. Dedepsidis, Z. Kyriakopoulou, V. Pliaka, C. Kottaridi, E. Bolanaki, S. Levidiotou-Stefanou, D. Komiotis, and P. Markoulatos
Retrospective Characterization of a Vaccine-Derived Poliovirus Type 1 Isolate from Sewage in Greece
Appl. Envir. Microbiol., November 1, 2007; 73(21): 6697 - 6704.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
Z. Kyriakopoulou, C. Kottaridi, E. Dedepsidis, E. Bolanaki, S. Levidiotou-Stefanou, and P. Markoulatos
Molecular Characterization of Wild-Type Polioviruses Isolated in Greece during the 1996 Outbreak in Albania.
J. Clin. Microbiol., March 1, 2006; 44(3): 1150 - 1152.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Shimizu, B. Thorley, F. J. Paladin, K. A. Brussen, V. Stambos, L. Yuen, A. Utama, Y. Tano, M. Arita, H. Yoshida, et al.
Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001
J. Virol., December 15, 2004; 78(24): 13512 - 13521.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
T. Hovi, N. Lindholm, C. Savolainen, M. Stenvik, and C. Burns
Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months
J. Gen. Virol., February 1, 2004; 85(2): 369 - 377.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Blomqvist, A.-L. Bruu, M. Stenvik, and T. Hovi
Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1
J. Gen. Virol., March 1, 2003; 84(3): 573 - 580.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
H. Triki, M. R. Barbouche, O. Bahri, M. Bejaoui, and K. Dellagi
Community-Acquired Poliovirus Infection in Children with Primary Immunodeficiencies in Tunisia
J. Clin. Microbiol., March 1, 2003; 41(3): 1203 - 1211.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. A. Cherkasova, E. A. Korotkova, M. L. Yakovenko, O. E. Ivanova, T. P. Eremeeva, K. M. Chumakov, and V. I. Agol
Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease
J. Virol., June 5, 2002; 76(13): 6791 - 6799.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
H. Horie, H. Yoshida, K. Matsuura, M. Miyazawa, Y. Ota, T. Nakayama, Y. Doi, and S. Hashizume
Neurovirulence of Type 1 Polioviruses Isolated from Sewage in Japan
Appl. Envir. Microbiol., January 1, 2002; 68(1): 138 - 142.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Georgopoulou, P. Markoulatos, N. Spyrou, and N. C. Vamvakopoulos
Improved Genotyping Vaccine and Wild-Type Poliovirus Strains by Restriction Fragment Length Polymorphism Analysis: Clinical Diagnostic Implications
J. Clin. Microbiol., December 1, 2000; 38(12): 4337 - 4342.
[Abstract] [Full Text]


Home page
Appl. Environ. Microbiol.Home page
K. Matsuura, M. Ishikura, H. Yoshida, T. Nakayama, S. Hasegawa, S. Ando, H. Horie, T. Miyamura, and T. Kitamura
Assessment of Poliovirus Eradication in Japan: Genomic Analysis of Polioviruses Isolated from River Water and Sewage in Toyama Prefecture
Appl. Envir. Microbiol., November 1, 2000; 66(11): 5087 - 5091.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
M. N. Mulders, M. Salminen, N. Kalkkinen, and T. Hovi
Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2Apro cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes
J. Gen. Virol., March 1, 2000; 81(3): 803 - 812.
[Abstract] [Full Text]


Home page
CVIHome page
T. Herremans, J. H. J. Reimerink, T. G. Kimman, H. G. A. M. van der Avoort, and M. P. G. Koopmans
Antibody Responses to Antigenic Sites 1 and 3 of Serotype 3 Poliovirus after Vaccination with Oral Live Attenuated or Inactivated Poliovirus Vaccine and after Natural Exposure
Clin. Vaccine Immunol., January 1, 2000; 7(1): 40 - 44.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1999 by the Society for General Microbiology.